FDA Approves Merck’s VAXNEUVANCE™ Pneumococcal 15-valent Conjugate Vaccine
Merck, also known as MSD, revealed that the U.S. Food and Drug Administration (FDA) has authorised VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate
Read moreMerck, also known as MSD, revealed that the U.S. Food and Drug Administration (FDA) has authorised VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate
Read moreThe University of Oxford has commenced a Phase I clinical trial of a novel HIV vaccine candidate with vaccinations underway
Read moreThe path for India’s first mRNA vaccine import has been cleared with Cipla winning approval to distribute Moderna’s COVID-19 vaccine.
Read morePharma giant Sanofi will spend €400 million annually towards a vaccines mRNA Center of Excellence, which will be the first
Read moreNucleai and Merck KGaA will collaborate utilizing Nucleai’s AI-powered platform to develop pathology-based biomarkers as companion diagnostics. Nucleai, a precision
Read moreInsilico Medicine, a Hong Kong-based pioneering biotechnology company, specialising in end-to-end artificial intelligence for target discovery, small molecule chemistry, and
Read moreThe legal dispute between the British-Swedish biopharmaceutical giant AstraZeneca and the European Union over a contract to deliver COVID-19 vaccines
Read moreThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the Pfizer-BioNTech vaccine in children aged 12-15
Read moreDanish multinational pharmaceutical company Novo Nordisk and Japanese cardiac regenerative medicine specialist Heartseed have confirmed an exclusive global partnership and license
Read moreGSK and Vir Biotechnology announced that the monoclonal antibody sotrovimab (VIR-7831) has received Emergency Use Authorization (EUA) from the US
Read more